Single and multiple doses of Indacaterol, a novel once-daily β2-agonists, are well tolerated in patients with mild asthma

被引：0
|
作者：
Brookman, L
Knight, H
Wood, J
Perry, S
Tarral, A
Elharrar, B
Pascoe, S
机构：
[1] Novartis Horsham Res Ctr, Horsham, W Sussex, England
[2] Biotrial, Paris, France
[3] Aster Cephac, Paris, France
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2006年 / 117卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2005.12.333
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
324
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [41] Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
    Kerstjens, Huib A. M.
    Maspero, Jorge
    Chapman, Kenneth R.
    van Zyl-Smit, Richard N.
    Hosoe, Motoi
    Tanase, Ana-Maria
    Lavecchia, Catherine
    Pethe, Abhijit
    Shu, Xu
    D'Andrea, Peter
    LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : 1000 - 1012
  • [42] QVA149 once-daily is safe and well tolerated and improves lung function and health status in Japanese patients with COPD: The ARISE study
    Asai, Kazuhisa
    Minakata, Yoshiaki
    Hirata, Kazuto
    Fukuchi, Yoshinosuke
    Kitawaki, Tetsuji
    Ikeda, Kimitoshi
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [43] Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study
    Beglinger, Christoph
    Hu, Ke
    Wang, Ying
    Bouillaud, Emmanuel
    Darstein, Christelle
    Wang, Yanfeng
    Mohideen, Pharis
    ENDOCRINE, 2012, 42 (02) : 366 - 374
  • [44] Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study
    Christoph Beglinger
    Ke Hu
    Ying Wang
    Emmanuel Bouillaud
    Christelle Darstein
    Yanfeng Wang
    Pharis Mohideen
    Endocrine, 2012, 42 : 366 - 374
  • [45] Assessment of Cortisol Levels with Once-Daily, Single-Inhaler Mometasone-Indacaterol-Glycopyrronium versus Mometasone-Indacaterol or Twice-Daily Fluticasone-Salmeterol in Patients with Inadequately Controlled Asthma: Post Hoc Analysis from the IRIDIUM Study
    Kerstjens, H. A. M.
    Van Zyl-Smit, R.
    D'Andrea, P.
    Hosoe, M.
    Pethe, A.
    Tanase, A-M
    Jain, D. K.
    Nikolaev, I
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [46] Once-daily quetiapine sustained release (SR) is effective and well tolerated in patients with schizophrenia switched from the same total daily dose of quetiapine immediate release (IR)
    Naber, D.
    Schimmelmann, B. G.
    Huber, C. G.
    Hundemer, H. P.
    Schacht, A.
    Wagner, T. T.
    Lambert, M.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 449 - 449
  • [47] Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial
    Devillier, Philippe
    Humbert, Marc
    Boye, Alain
    Zachgo, Wolfgang
    Jacques, Loretta
    Nunn, Carol
    West, Sarah
    Nicholls, Andy
    Antoun, Zeina
    Spinu, Luminita
    Grouin, Jean-Marie
    RESPIRATORY MEDICINE, 2018, 141 : 111 - 120
  • [48] Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma (vol 70, 102068, 2021)
    Buhl, Roland
    Nikolaev, Ivan
    Tillmann, Hanns-Christian
    Vaidya, Soniya
    Bartels, Christian
    Jain, Monish
    Jauernig, Juergen
    Kerstjens, Huib A. M.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 73
  • [49] Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial
    Ojanguren, Inigo
    Florencia Pilia, Maria
    BREATHE, 2021, 17 (01) : 1 - 5
  • [50] Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma
    Yurdakul, AS
    Taci, N
    Eren, A
    Sipit, T
    RESPIRATORY MEDICINE, 2003, 97 (12) : 1313 - 1319
12345